Search Results - "Esmat, GE"

Immunomodulators, sFas and Fas-L as potential noninvasive predictors of IFN treatment in patients with HCV genotype-4 by Zekri, A. R. N., Haleem, H. A., Esmat, G. E. -D., Bahnassy, A. A., El-Din, H. M. A., Hafez, M. M., Sharaby, A. F., Sharaf, H., Zakaria, M. S. E.-D.

“…Recent studies have indicated that cytokines can be used as markers for disease progression in hepatitis C virus (HCV)‐infected patients, therefore this study…”
Get full text

BMS-790052, A NS5A REPLICATION COMPLEX INHIBITOR, COMBINED WITH PEGINTERFERON ALFA-2A AND RIBIVIRIN IN TREATMENT-NAIVE HCV-GENO-TYPE 1 OR 4 PATIENTS: PHASE 2B AI444010 STUDY INTERIM WEEK 12 RESULTS by Hezode, C, Hirschfield, GM, Ghesquiere, W, Sievert, W, Rodriguez-Torres, M, Shafran, SD, Thuluvath, PJ, Tatum, HA, Waked, I, Esmat, GE, Lawitz, E, Rustgi, VK, Pol, S, Weis, N, Pockros, P, Bourliere, M, Serfaty, L, Vierling, JM, Fried, MW, Weiland, O, Brunetto, MR, Everson, GT, Zeuzem, S, Kwo, PY, Sulkowski, MS, Yin, PD, Diva, UA, Hughes, EA, Wind-Rotolo, M, Schnittman, SM

Get full text

Efficacy of Hepatitis B Vaccination in Primary School Children from a Village Endemic for Schistosoma mansoni by Bassily, Samir, Strickland, G. Thomas, Abdel-Wahab, Mohamed F., Esmat, Gamal E., Narooz, Shaker, El-Masry, Nabil A., Constantine, Niel T., Struewing, Jeffery P.

“…To determine whether chronic Schistosoma mansoni infection interferes with hepatitis B virus (HBV) immunization, 308 schoolchildren aged 6–12 years with no…”
Get full text